Researchers are exploring the use of bioinformatics analysis and secreted proteins to identify early warning biomarkers for cardio-renal syndrome. The focus appears to be on various types of cardio-renal syndrome, including type 2 and type 4, with the goal of improving early detection and diagnosis. The use of non-invasive methods, such as liquid biopsy and wearable sensors, is also being investigated for diagnosing related cardiovascular and renal conditions.